Skeletal Clinical improvement and skeletal muscle repair in GRMD dogs, after allogenic muscle Stem (MuStem) cell systemic delivery.

Archive ouverte

Rouger, Karl | Larcher, Thibaut | Dubreil, Laurence | Deschamps, Jack-Yves | Le Guiner, Caroline | Jouvion, Grégory | Delorme, Bruno | Lieubeau-Teillet, Blandine | Carlus, Marine | Fornasari, B | Deleau, S | Ledevin, Mireille | Guigand, Lydie | Cherel, Yan

Edité par CCSD -

Skeletal Clinical improvement and skeletal muscle repair in GRMD dogs, after allogenic muscle Stem (MuStem) cell systemic delivery.. Combined Meeting of the 17th ESGCT/16th German Society for Gene Therapy/4th German Society for Stem Cell Research

Consulter en ligne

Suggestions

Du même auteur

CELL THERAPY OF DUCHENNE MUSCULAR DYSTROPHY: PRECLINICAL TRIAL IN GRMD DOGS

Archive ouverte | Cherel, Yan | CCSD

National audience. Duchenne muscular dystrophy (DMD), a genetic progressive X-linked muscular dystrophy, is the most common genetic disease in humans. Cell therapy based on the use of somatic stem cells is a very pr...

Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.

Archive ouverte | Rouger, Karl | CCSD

Muscle Stem = MuStem. International audience. Duchenne muscular dystrophy (DMD) is a genetic progressive muscle disease resulting from the lack of dystrophin and without effective treatment. Adult stem cell populati...

Thérapie cellulaire de la Dystrophie musculaire de Duchenne. Thérapie cellulaire de la Dystrophie musculaire de Duchenne: Essai préclinique chez le chien myopathe

Archive ouverte | Cherel, Yan | CCSD

La dystrophie musculaire de Duchenne (DMD) est une maladie génétique progressive du muscle liéeau chromosome X. Elle est la maladie génétique la plus fréquente chez l’homme. La thérapie cellulairebasée sur l’utilisation de cellule...

Chargement des enrichissements...